Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

Celgene building

Celgene sets up stem cell deal with Mesoblast

Oncology drug specialist hoping to tap into possible treatments for Crohn's and cancer

- PMLiVE

FDA reviewer backs approval of TMC’s cangrelor

Claims it offers a small benefit over Sanofi’s Plavix

Pharma should ‘look beyond the sales cycle’ in digital

HCA meeting told the world won't wait for theindustry to engage

- PMLiVE

Vetter names Oliver Albrecht as managing director

He has over 20 years of industry experience

- PMLiVE

Novo Nordisk opens insulin facility in Russia

It will focus on new modern insulin formulation and filling

National Institute for Health and Care Excellence NICE logo

UK market access issues put on hold during election

NICE appraisals and Cancer Drugs Fund appeals will not be undertaken until May

- PMLiVE

Gilead under fire for Sovaldi anti-diversion policy

Accused as generic versions of the drug start to reach the market

EISAI

Eisai to make 200 cuts to US operations

Japanese firm says the restructure will help it stay competitive

- PMLiVE

AZ’s Onglyza may increase mortality, says FDA

Kombiglyze also under scrutiny

- PMLiVE

RSA name Kris Richards as senior consultant

Will aid the executive interims team

- PMLiVE

Pfizer launch grants programme for cardiovascular research

PCSK9 initiative is an extension of existing ASPIREprogramme

- PMLiVE

Pfizer and Merck flesh out Xalkori alliance details

First stage of building a combined oncology sales organisation

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links